279 related articles for article (PubMed ID: 21160030)
1. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells.
Slominski AT; Kim TK; Janjetovic Z; Tuckey RC; Bieniek R; Yue J; Li W; Chen J; Nguyen MN; Tang EK; Miller D; Chen TC; Holick M
Am J Physiol Cell Physiol; 2011 Mar; 300(3):C526-41. PubMed ID: 21160030
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.
Wasiewicz T; Piotrowska A; Wierzbicka J; Slominski AT; Zmijewski MA
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200275
[TBL] [Abstract][Full Text] [Related]
3. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
[TBL] [Abstract][Full Text] [Related]
4. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.
Janjetovic Z; Tuckey RC; Nguyen MN; Thorpe EM; Slominski AT
J Cell Physiol; 2010 Apr; 223(1):36-48. PubMed ID: 20020487
[TBL] [Abstract][Full Text] [Related]
5. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
7. Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23.
Wu W; Fan H; Jiang Y; Liao L; Li L; Zhao J; Zhang H; Shrestha C; Xie Z
Exp Dermatol; 2018 Nov; 27(11):1201-1209. PubMed ID: 30066343
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
[TBL] [Abstract][Full Text] [Related]
9. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity.
Li W; Chen J; Janjetovic Z; Kim TK; Sweatman T; Lu Y; Zjawiony J; Tuckey RC; Miller D; Slominski A
Steroids; 2010 Dec; 75(12):926-35. PubMed ID: 20542050
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
11. A new steroidal 5,7-diene derivative, 3beta-hydroxyandrosta-5,7-diene-17beta-carboxylic acid, shows potent anti-proliferative activity.
Kim TK; Chen J; Li W; Zjawiony J; Miller D; Janjetovic Z; Tuckey RC; Slominski A
Steroids; 2010 Mar; 75(3):230-9. PubMed ID: 20025893
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells.
Kim TK; Kleszczynski K; Janjetovic Z; Sweatman T; Lin Z; Li W; Reiter RJ; Fischer TW; Slominski AT
FASEB J; 2013 Jul; 27(7):2742-55. PubMed ID: 23620527
[TBL] [Abstract][Full Text] [Related]
13. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.
Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3659-67. PubMed ID: 19667162
[TBL] [Abstract][Full Text] [Related]
14. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
15. Novel vitamin D analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity.
Chen J; Wang J; Kim TK; Tieu EW; Tang EK; Lin Z; Kovacic D; Miller DD; Postlethwaite A; Tuckey RC; Slominski AT; Li W
Anticancer Res; 2014 May; 34(5):2153-63. PubMed ID: 24778017
[TBL] [Abstract][Full Text] [Related]
16. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
17. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.
Sølvsten H; Svendsen ML; Fogh K; Kragballe K
Arch Dermatol Res; 1997 May; 289(6):367-72. PubMed ID: 9209684
[TBL] [Abstract][Full Text] [Related]
19. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
